THE CLINICAL COURSE AND TREATMENT OF FUNGAL INFECTIONS IN THE EARLY PERIOD AFTER KIDNEY TRANSPLANTATION


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

The article discusses the critical issues of clinical manifestations and treatment of fungal infections in patients after kidney transplantation. In fungal infection, which is usually detected in the composition of microbial associations, lungs are more often affected. In this case, mortality reaches 60%. Affecting the renal transplant by Candida spp. or Aspergillus spp. can lead to the loss of function of transplanted kidneys. At the current stage, lipid formulations of amphotericin B are drugs of choice for antimycotic therapy in posttransplant period. Nephrotoxic effect of amphotericin B is reversible and does not represent a serious threat to the function of the transplantate. Administration of lipid formulations of amphotericin B is the most justified, since it does not affect the concentration of immunosuppressive drugs in the blood serum of patients after transplantation.

Толық мәтін

Рұқсат жабық

Әдебиет тізімі

  1. Denning D.W., Evans E.G., Kibbler C.C. Guidelines for the investigation of invasive fungal infections in haematological malignancy and solid organ transplantation. British Society for Medical Mycology. Eur. J. Clin. Microbiol. Infect. Dis. 1997;16(6): 424-436.
  2. Singh N., Gayowski T., Wagener M.M. et al. Invasive fungal infections in renal transplant recipients receiving tacrolimus as the primary immunosuppressive agent. Clin. Infect. Dis. 1997;24: 179-185.
  3. Odds F.C. Treatment of invasive fungal diseas: will combination antifungal therapy reduce martality? 13-th European Congress of Clinical Microbiology and Infectious Diseases May 10-13, 2003, Glasgow, UK
  4. Altiparmak M.R., Apaydin S., Trablus S. Systemic fungal infections after renal transplantation. Scand. J. Infect. Dis. 2002; 34(4): 284-288.
  5. Hibberd P.L., Rubin R.H. Clinical aspects of fungal infection in organ transplant recipients. Clin. Infect. Dis.-1994; 19 (Suppl. 1): S.33-40.
  6. Wu G., Vilchez R.A., Eidelman B. et al. Cryptococcal meningitis: an analysis among 5,521 consecutive organ transplant recipients. Transpl. Infect Dis. 2002; 4(4): 183-188.
  7. Colomba C., Antinori S. Fungal infections in transplantation patients. Recenti Prog. Med. 2003;94(11): 516-528.
  8. Echo A., Hovsepian R.V., Shen G.K. Localized cecal zygomycosis following renal transplantation. Transpl. Infect. Dis. 2005; 7(2): 68-70.
  9. Nampoory M.R., Khan Z.U., Johny K.V. et al. Nocardiosis in renal transplant recipients in Kuwait. Nephrol. Dial. Transplant. 1996; 11(6): 1134-1138.
  10. John G.H., Shankar V., Talaulicar G. et al. Epidemiology of systemic mycoses among renal-transplant recipients in India. Transplantation. 2003; 75: 1544-1551.
  11. Gabriel M. Danovitch. Handbook of Kidney Transplantation. Lippincott Williams@ Wilkins. 2004. P.471.
  12. van Hal S.J., Marriott D.J., Chen S.C. et al. Candidemia following solid organ transplantation in the era of antigungal prophilaxis: the Australian axperience. Transpl Infect Dis. 2009;11:122-127.
  13. Carol A. Kauffman., Gerald L. Mandell. Atlas of fungal infection. Springer. 2010:233.
  14. Dianne B. McKay, Steven M. Steinberg. Kidney Transplantation: A Guide to the Care of Kidney Transplant Recipients. Springer. 2010:407.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML

© Bionika Media, 2012

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>